MDCT vs. CBCT Guided Percutaneous Lung Nodule Biopsy: A Comparison of Pneumothorax Incidence and Associated Risk Factors

NCT ID: NCT05344430

Last Updated: 2023-05-16

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-07-08
• Study Completion Date: 2024-07-08

Brief Summary

The goal of this study is to determine if cone beam computed tomography (CBCT) is a viable alternative imaging guidance modality for percutaneous transthoracic needle biopsy (PTNB) in a community hospital-based practice, and to determine the incidence of CBCT PTNB-associated pneumothorax compared to multidetector computed tomography (MDCT) guided PTNB biopsy. The standard of care in this facility is MDCT guided PTNB biopsy. The experimental arm of this study is CBCT-guided PTNB biopsy.

This prospective study will identify patients planned for PTNB. Thereafter, data on lesion characteristics, imaging findings, and clinical history will be collected. Patients will be subsequently randomly assigned to undergo biopsy using either CBCT or MDCT guidance. This study will analyze the pneumothorax incidence between groups, and assess for associations between lesion size/location, pertinent imaging findings, and clinical risk factors.

Detailed Description

Studies have shown that CBCT is a viable imaging modality for PTNB. Although MDCT-guidance remains the preferred procedural modality, research has shown that CBCT-guided biopsies can be carried out safely and effectively. Particularly, studies demonstrate a satisfactory diagnostic yield, low complication rate, and overall reduced patient radiation dose. However, only a handful of studies have compared this method to MDCT-guided biopsy.

In this 248-bed community hospital-based interventional radiology practice, C-Arm CBCT was successfully utilized during a three-month period when a dedicated procedural CT scanner was out of service prior to the installation of a new machine. During this time, CBCT was used to perform PTNB. This study was prompted given the operators' perception that there was an overall increased incidence of biopsy-associated pneumothoraxes. Given this subjective experience, a retrospective analysis was carried out comparing the complication rate during these three months to the preceding six-month period, when MDCT-guidance was primarily used.

For the primary analysis, patients were grouped based on imaging modality (CBCT n=37; CT n=64). Multiple Pearson Chi-Square Tests were carried out using p=.05 as the statistical threshold. Additional analyses dividing patient based on lesion size (≥/< 2 cm in diameter), lesion pleural depth (≥/< 2 cm pleural depth), bullous lung change on imaging, chest tube placement, history of COPD, and smoking history were also carried out to assess for related pneumothorax risk factors.

The investigators found no significant association between the imaging modality used for PTNB and subsequent pneumothorax (p=.69). However, there was a significant interaction between chest tube placement and diagnosed chronic obstructive pulmonary disease (COPD) (p=.03), where among all study subjects, 6 of the 8 patients requiring a chest tube had a history of chronic obstructive pulmonary disease (COPD). Additionally, all patients requiring chest tube placement were either current or former smokers. This finding approached but did not reach statistical significance (p=0.12).

This study did not confirm the perceived increased pneumothorax rate. However, the findings corroborate previously published literature, where complication rates between CBCT and MDCT-guidance are reportedly comparable. This experience demonstrates that CBCT can be successfully utilized in a community hospital setting, where limited resources often prompt the need for alternative and innovative procedural approaches.

Outcomes:

To determine the incidence of pneumothorax as a complication of CBCT and CT-guided percutaneous lung biopsy.

To determine if there is an association between biopsy imaging guidance modality, lesion characteristics, and associated clinical risk factors.

To collect data that may be used in the future for biopsy modality risk stratification. This is significant, since resource allocation in community hospital settings may be necessary more frequently, compared to larger hospital settings. Therefore, proper risk stratification is needed for appropriate delivery of high quality and safe patient care.

Methods:

The Interventional Radiology department at Mather Hospital has a robust referral volume from the community oncologists and pulmonologist. In the past year, over 150 CT-guided PTNBs of the lung were performed.

The number of patients that can be recruited for this study is essentially unlimited. The only limiting factor would be the number of lung biopsies scheduled in the study institution per year.

Research protocols will be distributed to the scheduling staff to make them aware of the randomization process, to enable appropriate scheduling of research participants to the correct imaging modality and procedure room.

Outpatients scheduled for lung biopsy will be identified by the departmental interventional radiologists.

This study is exploratory in nature. As a result, the investigators are estimating that 50 patients per treatment arm is sufficient to detect a moderate effect size difference between groups.

Conditions

Lung Diseases

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

cone beam computed tomography (CBCT) for percutaneous transthoracic needle biopsy

Cone beam Computed Tomography (CBCT) with Navigational software guidance for percutaneous transthoracic needle biopsy

Group Type: OTHER

cone beam computed tomography (CBCT) for percutaneous transthoracic needle biopsy

Intervention Type: PROCEDURE

We will be conducting cone beam computer tomography for percutaneous transthoracic needle biopsies.

multidetector computed tomography (MDCT) for percutaneous transthoracic needle biopsy

Multidetector Computer Tomography for percutaneous transthoracic needle biopsy

Group Type: OTHER

cone beam computed tomography (CBCT) for percutaneous transthoracic needle biopsy

Intervention Type: PROCEDURE

We will be conducting cone beam computer tomography for percutaneous transthoracic needle biopsies.

Interventions

cone beam computed tomography (CBCT) for percutaneous transthoracic needle biopsy

We will be conducting cone beam computer tomography for percutaneous transthoracic needle biopsies.

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• Patients scheduled for lung biopsy at Mather Hospital's Department of Interventional Radiology.
• Patients ages from 18 years old to 90 years old.

Exclusion Criteria

• High risk patients will be excluded from the study.
• ( High risk - Any patient with severe emphysema with bullous emphysema on baseline Computed Tomography of the Chest, intended biopsy target/nodule adjacent to an airway or central vasculature, or less than 1 cm in size)
• Patients less than 18 years old
• Patients older than 90 years old
• patients who lack mental capacity for medical decision making
• Any patient requiring or requesting general anesthesia for the intended procedure

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 90 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Northwell Health

OTHER

Sponsor Role: lead

Responsible Party

Kenny Lien

Interventional Radiologist

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Kenny Lien, MD

Role: PRINCIPAL_INVESTIGATOR

Interventional Radiologist

Locations

Mather Hospital Northwell Health

Port Jefferson, New York, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Kenny Lien, MD

Role: CONTACT

klien@northwell.edu

631-473-1320

Greg Haggerty, PhD

Role: CONTACT

ghaggerty@northwell.edu

516-551-8655

Facility Contacts

Kenny Lien, MD

Role: primary

klien@northwell.edu

631-473-1320

Greg Haggerty, PhD

Role: backup

ghaggerty@northwell.edu

516-551-8655

Other Identifiers

20-1058-MATHER

Identifier Type: -

Identifier Source: org_study_id